Hanna GJ - Search Results

1

Hanna GJ. Hanna GJ. Hematol Oncol Clin North Am. 2021 Oct;35(5):xiii-xiv. doi: 10.1016/j.hoc.2021.07.013. Hematol Oncol Clin North Am. 2021. PMID: 34503736 No abstract available.

2

Cancer Precursor Syndromes and Their Detection in the Head and Neck.

Villa A, William WN Jr, Hanna GJ. Villa A, et al. Among authors: hanna gj. Hematol Oncol Clin North Am. 2024 May 4:S0889-8588(24)00033-9. doi: 10.1016/j.hoc.2024.04.001. Online ahead of print. Hematol Oncol Clin North Am. 2024. PMID: 38705773 Review.

3

Chimeric Antigen Receptor T-Cell Therapy for Solid Tumors.

Wala JA, Hanna GJ. Wala JA, et al. Among authors: hanna gj. Hematol Oncol Clin North Am. 2023 Dec;37(6):1149-1168. doi: 10.1016/j.hoc.2023.05.009. Epub 2023 Jun 21. Hematol Oncol Clin North Am. 2023. PMID: 37353377 Review.

4

Hospitalization rates and 30-day all-cause mortality among head and neck cancer patients and survivors with COVID-19.

Hanna GJ, Rettig EM, Park JC, Varvares MA, Lorch JH, Margalit DN, Schoenfeld JD, Tishler RB, Goguen LA, Annino DJ Jr, Haddad RI, Uppaluri R. Hanna GJ, et al. Oral Oncol. 2021 Jan;112:105087. doi: 10.1016/j.oraloncology.2020.105087. Epub 2020 Nov 6. Oral Oncol. 2021. PMID: 33190021 Free PMC article.

5

A phase II trial of all-trans retinoic acid (ATRA) in advanced adenoid cystic carcinoma.

Hanna GJ, ONeill A, Cutler JM, Flynn M, Vijaykumar T, Clark JR, Wirth LJ, Lorch JH, Park JC, Mito JK, Lohr JG, Kaufman J, Burr NS, Zon LI, Haddad RI. Hanna GJ, et al. Oral Oncol. 2021 Aug;119:105366. doi: 10.1016/j.oraloncology.2021.105366. Epub 2021 Jun 3. Oral Oncol. 2021. PMID: 34091189 Clinical Trial.

6

Integrated genomic characterization of oral carcinomas in post-hematopoietic stem cell transplantation survivors.

Hanna GJ, Kofman ER, Shazib MA, Woo SB, Reardon B, Treister NS, Haddad RI, Cutler CS, Antin JH, Van Allen EM, Uppaluri R, Soiffer RJ. Hanna GJ, et al. Oral Oncol. 2018 Jun;81:1-9. doi: 10.1016/j.oraloncology.2018.04.007. Epub 2018 Apr 10. Oral Oncol. 2018. PMID: 29884406

7

Radiologic predictors of immune checkpoint inhibitor response in advanced head and neck squamous cell carcinoma.

Sridharan V, Rahman RM, Huang RY, Chau NG, Lorch JH, Uppaluri R, Haddad RI, Hanna GJ, Schoenfeld JD. Sridharan V, et al. Among authors: hanna gj. Oral Oncol. 2018 Oct;85:29-34. doi: 10.1016/j.oraloncology.2018.08.005. Epub 2018 Aug 17. Oral Oncol. 2018. PMID: 30220316

8

Salivary HPV DNA informs locoregional disease status in advanced HPV-associated oropharyngeal cancer.

Hanna GJ, Lau CJ, Mahmood U, Supplee JG, Mogili AR, Haddad RI, Jänne PA, Paweletz CP. Hanna GJ, et al. Oral Oncol. 2019 Aug;95:120-126. doi: 10.1016/j.oraloncology.2019.06.019. Epub 2019 Jun 20. Oral Oncol. 2019. PMID: 31345379

9

Chemotherapy after immune checkpoint blockade in patients with recurrent, metastatic squamous cell carcinoma of the head and neck.

Kacew AJ, Harris EJ, Lorch JH, Schoenfeld JD, Margalit DN, Kass JI, Tishler RB, Haddad RI, Hanna GJ. Kacew AJ, et al. Among authors: hanna gj. Oral Oncol. 2020 Jun;105:104676. doi: 10.1016/j.oraloncology.2020.104676. Epub 2020 Apr 3. Oral Oncol. 2020. PMID: 32251982

10

Long-term outcomes and clinicogenomic correlates in recurrent, metastatic adenoid cystic carcinoma.

Hanna GJ, Bae JE, Lorch JH, Schoenfeld JD, Margalit DN, Tishler RB, Haddad RI, Chau NG. Hanna GJ, et al. Oral Oncol. 2020 Jul;106:104690. doi: 10.1016/j.oraloncology.2020.104690. Epub 2020 Apr 11. Oral Oncol. 2020. PMID: 32283496

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

169 results

Search Page